Medical term:
M
nitrofurantoin
nitrofurantoin macrocrystals
Pharmacologic class: 5-nitrofuran derivative
Therapeutic class: Anti-infective, urinary tract anti-infective
Pregnancy risk category B
Action
Inhibits bacterial enzymes required for normal cell activity at low concentrations; inhibits normal cell-wall synthesis at high concentrations
Availability
Capsules: 25 mg, 50 mg, 100 mg (macrocrystals)
Capsules (extended-release): 100 mg (macrocrystals)
Oral suspension: 25 mg/5 ml
Tablets: 50 mg, 100 mg (macrocrystals)
Indications and dosages
➣ Active urinary tract infections (UTIs)
Adults: 50 to 100 mg P.O. q.i.d. or 100 mg q 12 hours (extended-release), continued for 1 week, or for 3 days after urine becomes sterile
Children older than 1 month: 5 to 7 mg/kg/day P.O. in four divided doses, continued for 1 week, or for 3 days after urine becomes sterile
➣ Chronic suppression of UTIs
Adults: 50 to 100 mg P.O. at bedtime
Children: 1 mg/kg/day P.O. in one or two divided doses
Contraindications
• Hypersensitivity to drug or parabens (oral suspension)
• Oliguria, anuria, or significant renal impairment
• Pregnancy near term (38 to 42 weeks' gestation), imminent labor onset, labor and delivery
• Infants younger than 1 month
Precautions
Use cautiously in:
• diabetes mellitus, renal impairment
• blacks and patients of Mediterranean or near-Eastern descent (because of possible G6PD deficiency)
• elderly or debilitated patients
• pregnant (to week 32) or breastfeeding patients.
Administration
• As appropriate, obtain specimens for repeat urine culture and sensitivity tests before therapy.
• To avoid GI upset and increase drug bioavailability, give with food or milk.
Adverse reactions
CNS: dizziness, drowsiness, headache, asthenia, peripheral neuropathy, vertigo
CV: chest pain
EENT: nystagmus
GI: nausea, vomiting, diarrhea, abdominal pain, anorexia, parotitis, pancreatitis
Hematologic: eosinophilia, agranulocytosis, thrombocytopenia, leukopenia, granulocytopenia, G6PD deficiency anemia, hemolytic anemia, megaloblastic anemia
Hepatic: hepatitis, hepatic necrosis
Musculoskeletal: arthralgia, myalgia
Respiratory: asthma attacks, pulmonary hypersensitivity reactions including diffuse interstitial pneumonias (with prolonged therapy)
Skin: rash, exfoliative dermatitis, alopecia, pruritus, urticaria, angioedema, photosensitivity, Stevens-Johnson syndrome
Other: drug fever, chills, superinfection (limited to urinary tract), hypersensitivity reactions including anaphylaxis, lupus-like syndrome
Interactions
Drug-drug. Anticholinergics: increased nitrofurantoin absorption and bioavailability
Drugs that can cause pulmonary toxicity: increased risk of pneumonitis
Hepatotoxic drugs: increased risk of hepatotoxicity
Magnesium salts: decreased nitrofurantoin absorption
Neurotoxic drugs: increased risk of neu-rotoxicity
Uricosurics (such as probenecid): decreased renal clearance and increased blood level of nitrofurantoin
Drug-diagnostic tests. Alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, bilirubin, blood urea nitrogen, creatinine: increased levels Granulocytes, platelets, hemoglobin: decreased levels
Urine glucose tests using Benedict's reagent or Fehling's solution: false-positive results
Drug-food. Any food: increased drug bioavailability
Patient monitoring
• Monitor patient's response to therapy. Assess urine culture and sensitivity tests.
Watch for and immediately report peripheral neuropathy.
Assess respiratory status. Watch for signs and symptoms of serious pulmonary hypersensitivity reaction.
Monitor CBC and liver function tests closely. Stay alert for evidence of hematologic and hepatic disorders.
• Evaluate patient for rash.
Patient teaching
• Instruct patient to take with food or milk at regular intervals around the clock.
• Advise patient to complete entire course of therapy.
• Tell patient not to take magnesium-containing drugs (such as antacids) during therapy.
• Caution patient not to drive or perform other hazardous activities until he knows how drug affects vision, concentration, and alertness.
Tell patient to immediately report fever, chills, cough, chest pain, difficulty breathing, rash, bleeding or easy bruising, dark urine, yellowing of skin or eyes, numbness or tingling of fingers or toes, or intolerable GI distress.
• Advise female patient to avoid taking drug during pregnancy, especially near term.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, and foods mentioned above.
nitrofurantoin
(nye-troe-fyoor-an-toyn) ,Furadantin
(trade name),Furantoin
(trade name),Macrobid
(trade name),Macrodantin
(trade name)Classification
Therapeutic: anti infectivesIndications
Action
Therapeutic effects
- Citrobacter,
- Corynebacterium,
- Enterobacter,
- Escherichia coli,
- Klebsiella,
- Neisseria,
- Salmonella,
- Shigella,
- Staphylococcus aureus,
- Staphylococcus epidermidis,
- Enterococcus.
Pharmacokinetics
Time/action profile (urine levels)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
PO | unknown | 30 min | 6–12 hr |
Contraindications/Precautions
Adverse Reactions/Side Effects
Central nervous system
- dizziness
- drowsiness
- headache
Ear, Eye, Nose, Throat
- nystagmus
Respiratory
- pneumonitis (life-threatening)
- pulmonary fibrosis (life-threatening)
Cardiovascular
- chest pain
Gastrointestinal
- hepatotoxicity (life-threatening)
- pseudomembranous colitis (life-threatening)
- anorexia (most frequent)
- nausea (most frequent)
- vomiting (most frequent)
- abdominal pain
- diarrhea
Genitourinary
- rust/brown discoloration of urine
Dermatologic
- photosensitivity
Hematologic
- blood dyscrasias
- hemolytic anemia
Neurologic
- peripheral neuropathy
Miscellaneous
- hypersensitivity reactions (most frequent)
Interactions
Drug-Drug interaction
Probenecid prevents high urinary concentrations; may ↓ effectiveness.Antacids may ↓ absorption.↑ risk of neurotoxicity with neurotoxic drugs.↑ risk of hepatotoxicity with hepatotoxic drugs.↑ risk of pneumonitis with drugs having pulmonary toxicity.Route/Dosage
Availability (generic available)
Nursing implications
Nursing assessment
- Assess for signs and symptoms of urinary tract infection (frequency, urgency, pain, and burning on urination; fever; cloudy or foul-smelling urine) before and periodically during therapy.
- Obtain specimens for culture and sensitivity before and during drug administration.
- Monitor intake and output ratios. Report significant discrepancies in totals.
- Monitor bowel function. Diarrhea, abdominal cramping, fever, and bloody stools should be reported to health care professional promptly as a sign of pseudomembranous colitis. May begin up to several weeks following cessation of therapy.
- Assess for signs and symptoms of pulmonary reactions periodically during therapy. Acute reactions (fever, chills, cough, chest pain, dyspnea, pulmonary infiltration with consolidation or pleural effusion on x-ray, eosinophilia) usually occur within first week of treatment and resolve when therapy is discontinued. Chronic reactions (malaise, dyspnea on exertion, cough, altered pulmonary function) may indicate pneumonitis or pulmonary fibrosis and are more common in patients taking nitrofurantoin for 6 mo or longer.
- Lab Test Considerations: Monitor CBC routinely with patients on prolonged therapy.
- Monitor liver function tests periodically during therapy. May cause ↑ serum glucose, bilirubin, alkaline phosphatase, BUN, and creatinine. If hepatotoxicity occurs, discontinue therapy.
- Monitor renal function periodically during therapy.
Potential Nursing Diagnoses
Risk for infection (Indications)Implementation
- Oral: Administer with food or milk to minimize GI irritation, to delay and increase absorption, to increase peak concentration, and to prolong duration of therapeutic concentration in the urine.
- Do not crush tablets or open capsules.
- Administer liquid preparations with calibrated measuring device. Shake well before administration. Oral suspension may be mixed with water, milk, fruit juices, or infant formula. Rinse mouth with water after administration of oral suspension to avoid staining teeth.
Patient/Family Teaching
- Instruct patient to take medication around the clock, as directed. Take missed doses as soon as remembered and space next dose 2–4 hr apart. Do not skip or double up on missed doses.
- May cause dizziness or drowsiness. Caution patient to avoid driving or other activities requiring alertness until response to medication is known.
- Inform patient that medication may cause a rust-yellow to brown discoloration of urine, which is not significant.
- Advise patient to notify health care professional if fever, chills, cough, chest pain, dyspnea, skin rash, numbness or tingling of the fingers or toes, or intolerable GI upset occurs. Signs of superinfection (milky, foul-smelling urine; perineal irritation; dysuria) should also be reported.
- Instruct patient to notify health care professional if fever and diarrhea develop, especially if stool contains blood, pus, or mucus. Advise patient not to treat diarrhea without consulting health care professional.
- Instruct patient to consult health care professional if no improvement is seen within a few days after initiation of therapy.
Evaluation/Desired Outcomes
- Resolution of the signs and symptoms of infection. Therapy should be continued for a minimum of 7 days and for at least 3 days after the urine has become sterile.
- Decrease in the frequency of infections in chronic suppressive therapy.
Macrobid
A brand name for NITROFURANTOIN.Marijuana
Definition
Description
History
Controversy
Purpose
Preparations
Precautions
Side effects
Key terms
Interactions
Resources
Books
Periodicals
Other
marijuana
[mar″ĭ-wahn´ah]tetrahydrocannabinol (THC), the most active ingredient of marijuana, can, with heavy smoking, narrow the bronchi and bronchioles and produce inflammation of the mucous membranes. In addition, marijuana smoke contains many of the same chemicals and “tars” as tobacco smoke and, therefore, increases the risk of lung cancer. There is some evidence that marijuana increases the risk for miscarriage and birth defects. Even though these dangers have not been completely documented, it is recommended that both men and women who plan to have children should avoid marijuana as they would any other unnecessary drug.
One beneficial effect of THC is the lowering of intraocular pressure, which can be helpful in the control of glaucoma. However, because it causes tachycardia and increased work for the heart, it cannot be used in most elderly persons, the age group in which glaucoma is most prevalent. Another use of THC is for relief of extreme nausea and vomiting in patients undergoing cancer chemotherapy, although not every patient responds favorably to THC.
marijuana
alsomarihuana
(măr′ə-wä′nə)Herbal medicine MJ is listed in ancient pharmacopeias of China, and used for pain, insomnia, nervous complaints
Mainstream medicine MJ has been evaluated as an appetite stimulant and as a way to control nausea due to chemotherapy, and as beneficial for asthma, glaucoma and seizures; see below, Therapeutics
Substance abuse A substance derived from the hemp plant Cannabis sativa, the leaves of which are smoked, producing a hallucinogenic effect due to the neurochemical delta9-tetrahydrocannabinol (THC), which has a cognate THC receptor in the brain
Effects
Immune system THC blocks monocyte maturation
Nervous system Impaired motor skills, defective eye tracking and perception; THC receptors are most abundant in the hippocampus, where memory is consolidated—explaining MJ’s detrimental effect on memory—and least abundant in the brainstem, explaining why death by overdose is unknown with chronic marijuana abuse
Pregnancy Heavy use is associated with residual neuropsychological effects, as evidenced by increased perseverations on card-sorting, and decreased learning of lists
Respiratory tract MJ is inhaled or ‘toked’ in a fashion that differs from that of tobacco; in order to maximize THC absorption and elicit the desired ‘high’, the subject prolongs inhalation, markedly increasing carbon monoxide and tar. Thus it may be more detrimental than tobacco smoke
Therapeutics MJ is an analgesic, but unusable as such, due to the inseparable hallucinogenic effect; it is of use for
(1) Control of nausea and vomiting in terminal cancer. Two antiemetic cannabinoids are commercially available, nabilone—Cesamet, a synthetic derivative of MJ—and dronabinol—Marinol, the principle psychoactive substance in MJ; both are 2nd-line therapies, given their psychotomimetic effects and side effects—drowsiness, dizziness, vertigo, loss of ability to concentrate and mood swings.
(2) Control of intraocular pressure in open-angle glaucoma, administered orally, in topical drops or smoked; MJ may evoke anxiety or panic attacks
Route Inhaled, oral
Pharmacologic effects Hallucinations, euphoria, relaxed inhibitions, increased appetite, disorientation, increased pulse rate, reddening of conjunctiva
Toxicology THC and metabolites are detectable in urine 1 hr after smoking, later if used as a garnee—i.e., 'pot in a pan'
marijuana
Cannabis sativa, C indica MJ Herbal medicine MJ is listed in ancient pharmacopeias of China, and used for pain, insomnia, nervous complaints Mainstream medicine MJ has been evaluated as an appetite stimulant, and to control asthma, glaucoma, seizures, and nausea due to chemotherapy. See Herbal medicine, THC Substance abuse A substance derived from the hemp plant Cannabis sativa, the leaves of which are smoked, producing a hallucinogenic effect due to the neurochemical Δ9-tetrahydrocannabinol–THC, which has a cognate THC receptor in the brain Immune system THC blocks monocyte maturation Nervous system Impaired motor skills, defective eye tracking and perception; THC receptors are most abundant in the hippocampus, where memory is consolidated, explaining MJ's detrimental effect on memory and least abundant in the brainstem, explaining why death by overdose is unknown with chronic marijuana abuse; heavy use is associated with residual neuropsychological effects, as evidenced by ↑ perseverations on card-sorting, and ↓ learning of lists Respiratory tract MJ is inhaled or 'toked' in a fashion that differs from that of tobacco; in order to maximize THC absorption and elicit the desired 'high. ', the subject prolongs inhalation, markedly ↑ carbon monoxide and tar, and thus is possibly more detrimental than tobacco smoke Therapeutic uses MJ is an analgesic, but unusable as such, due to the inseparable hallucinogenic effect; it is of use formar·i·jua·na
, marihuana (mar'i-hwahn'ă)See also: cannabis
marijuana
, marihuana (mar?i-wan'a) [Mexican Sp. marihuana, mariguana]Its active ingredient, delta-9-tetrahydrocannabinol (THC), may produce euphoria, alterations in mood and judgment, and changes in sensory perception, cognition, and coordination. Driving and machine-operating skills may be impaired. Users of marijuana have impaired short-term memory; memory deficits are transient, however, and return to normal within about a week of abstinence. Depending on the dose of the drug and the underlying psychological conditions of the user, marijuana may cause transient episodes of confusion, anxiety, or delirium. Its use may exacerbate mental illness, esp. schizophrenia. Long-term, relatively heavy use may be associated with behavioral disorders and a kind of ennui called the amotivational syndrome, but it is not known whether use of the drug is a cause or a result of this condition. Transient symptoms occur on withdrawal, indicating that the drug can lead to physical dependence. There has been considerable interest in the effects of marijuana on pregnancy and fetal growth, but substance abusers often abuse more than a single substance, making it difficult to evaluate the effects of individual substances on the outcome of pregnancy or fetal development.
There is no definitive evidence that prolonged heavy smoking of marijuana leads to impaired pulmonary function. The possibility that chronic marijuana use is associated with an increased risk of developing head and neck cancer exists, but it has not been proven.
Delta-9-tetrahydrocannabinol, also known as dronabinol, is approved for use in treating nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatment, and treatment of anorexia associated with weight loss in patients with acquired immunodeficiency syndrome. Marijuana has also been approved for other medical uses in some states, although such use violates federal Drug Enforcement Administration standards.
CAUTION!
Dronabinol is a controlled substance. Prescriptions are limited to the amount necessary for a single cycle of chemotherapy.medical marijuana
marijuana
See CANNABIS.marijuana
cannabis.Patient discussion about marijuana
Q. what are the requirements of getting medicinal marijuana? i'd like to know the requirements of getting prescribed medicinal marijuana. i have heard alot about health benefits of moderate use of marijuana or should i refer to it as cannabis.
Q. My 37 year old son is depressed. He uses marijuana and alcohol daily - how can I help him? He refuses to obtain professional help (says the drugs they give you are harmful). Says his drinking is due to his genes, and there is little he can do about it. Has run up 70k in credit card debt. Does not want to quit smoking weed, and drinking booze.
Q. One of my friends is an addict to Alcohol. Which one is worse? Marijuana or alcohol One of my friends is an addict to Alcohol. He later stopped and started using Marijuana. Which one is worse? Marijuana or alcohol
Latest Searches:
Voraxaze - Voranil - Voorhoeve - voodoo - VOO - Vontrol - von - vomitus - vomiturition - vomitory - vomitoria - vomito - vomitive - vomiting - vomit - vomica - vomerovaginalis - vomerovaginal - vomerorostralis - vomerorostral -
- Service manuals - MBI Corp